“…For mice that underwent chemogenetic manipulations, adult males (8-9 weeks old) received viral micro-infusion in the same surgery as head bar attachment, similar to previously described protocol ( 46 ). Specifically, AAV8-hSyn-DIO-hM3D(Gq)-mCherry (Addgene, 44361-AAV8, 2.9 x 10 13 vg/ml) or AAV8-hSyn-DIO-mCherry (Addgene, 50459-AAV8, 1.0 x 10 13 vg/ml) was micro-infused in vCA1 bilaterally (500 nL per hemisphere, -3.52 mm AP, ±3.1 ML, -4.2 [150 nL], -4.1 [200 nL] and -4.0 [150 nL] DV, from bregma according to Paxinos and Franklin [2011]), and AAV2retro-CAG-Cre (UNC Vector Core, Ed Boyden’s stock, 4.1x10 12 vg/ml) was micro-infused in BLA bilaterally (500 nL per hemisphere, -1.80 mm AP, ±3.1 ML, -5.0 [150 nL], -4.8 [200 nL] and -4.6 [150 nL] DV).…”